Show simple item record

dc.contributor.authorChek, JBL
dc.contributor.authorWerimo, K
dc.date.accessioned2015-07-16T07:55:31Z
dc.date.available2015-07-16T07:55:31Z
dc.date.issued2000
dc.identifier.citationEast African Medical Journal 2000 Vol. 77 No. 12 pp. 639en_US
dc.identifier.urihttp://www.cabdirect.org/abstracts/20013048877.html?resultNumber=1&q=au%3A%22Chek%2C+J.+B.+L.%22
dc.identifier.urihttp://hdl.handle.net/11295/87878
dc.description.abstractA total of 96 residents in Kenya, who had life-long, intense exposure to malaria, donated blood samples for malaria parasite smears [date not given]. Each volunteer was then treated with a single dose of 3 tablets of pyrimethamine-sulfadoxine (Fansidar), followed by 100 mg of doxycycline twice daily for 7 days. Volunteers were visited for the next 96 days and blood smears were analysed on days 7, 14, 28, 42, 56, 70, 84 and 98, and any other day a volunteer complained of illness. Of 82 who completed the study, 32 (39%) had P. falciparum on day 0. Between day 42 and 96, there was a gradual increase in the cumulative proportion with parasitaemia. By day 96, 60 (75%) had become positive. Seventy-five percent had P. falciparum reinfection within 96 days after radical treatment and was referred to as "early reinfected" group, whereas the remaining 25% who did not develop reinfection within the study period was classified as "delayed reinfected" group.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleConceptual basis of 'early' and 'delayed' reinfection with Plasmodium falciparum.en_US
dc.typeArticleen_US
dc.type.materialenen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record